Messenger RNA: CureVac files a complaint against its rival BioNTech

Messenger RNA: CureVac files a complaint against its rival BioNTech

The German biotechnology laboratory CureVac has filed a complaint against its rival BioNTech, designer with Pfizer of one of the main anti-Covid vaccines. He alleges intellectual property infringement regarding innovative messenger RNA technology. “BioNTech’s work is original and we will vigorously defend it against any allegations of patent infringement,” BioNTech said in a statement. CureVac …

Messenger RNA: CureVac files a complaint against its rival BioNTech Read More »